Skip to content

Member

Elena NEVADO DEL CAMPO

EPP · Spain

Group
EPP PPE
Country
Spain
Roll-call participation
88.2 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
95.2 %ⓘ of 547 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
PP Partido Popular
In office
Since 16 Jul 2024
Against clear line
16 of 511 votesⓘ
Committees
FEMM (substitute), PETI, REGI, SANT
Member id
257039
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

88.2 %

547 of 620 final votes while in office

EPP median: 90.6 % (−2.3 pts)

Chamber median: 90.6 %

With majority line ⓘ

95.2 %

521 of 547 votes where their group had a line

EPP median: 95.6 % (−0.3 pts)

Against clear line ⓘ

3.1 %

16 of 511 votes where their group had a clear line

7 opposite (for ↔ against), 9 abstained against the line

Abstention ⓘ

2.4 %

13 of 547 votes cast

Participation 88.2 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Elena NEVADO DEL CAMPO88.2 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 95.2 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Elena NEVADO DEL CAMPO95.2 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Adopted 459 for, 12 against, 86 abstainedPosition: For Majority line: For
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Adopted 374 for, 198 against, 19 abstainedPosition: For Majority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Adopted 514 for, 61 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Adopted 562 for, 1 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Adopted 395 for, 136 against, 80 abstainedPosition: For Majority line: For
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Adopted 467 for, 92 against, 44 abstainedPosition: No vote recorded Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Adopted 368 for, 172 against, 69 abstainedPosition: For Majority line: For
17 Sept 2026Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers Adopted 601 for, 4 against, 5 abstainedPosition: For Majority line: For
17 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders Adopted 339 for, 225 against, 16 abstainedPosition: For Majority line: For
17 Sept 2026Strengthening global health resilience in partner countries Adopted 319 for, 142 against, 19 abstainedPosition: For Majority line: For
16 Sept 2026Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) Passed 549 for, 92 against, 27 abstainedPosition: For Majority line: For
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) Passed 540 for, 105 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Passed 530 for, 125 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Passed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Passed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Passed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Consent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Consent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Objection passed 442 for, 184 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Genetically modified soybean MON 94313 Objection passed 457 for, 184 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Genetically modified maize MON 87460 Objection passed 433 for, 159 against, 10 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Adopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Adopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Adopted 390 for, 218 against, 29 abstainedPosition: Against Majority line: Against
15 Sept 2026Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures Passed 464 for, 50 against, 159 abstainedPosition: For Majority line: For
15 Sept 2026Establishing the Temporary Decarbonisation Fund Passed 433 for, 97 against, 146 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances Passed 367 for, 240 against, 59 abstainedPosition: Against ≠ groupMajority line: For
15 Sept 2026Market stability reserve for the buildings, road transport and additional sectors Passed 467 for, 158 against, 41 abstainedPosition: Abstained ≠ groupMajority line: For
15 Sept 2026Implementation into Union law of measures adopted by regional fisheries management organisations Passed 559 for, 48 against, 62 abstainedPosition: For Majority line: For
15 Sept 2026General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area Passed 580 for, 51 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Temporary trade-liberalisation measures applicable to Armenian products Passed 583 for, 49 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure Passed 440 for, 127 against, 104 abstainedPosition: For Majority line: For
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield Adopted 420 for, 220 against, 26 abstainedPosition: For Majority line: For
15 Sept 2026Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee Adopted 530 for, 77 against, 61 abstainedPosition: For Majority line: For
15 Sept 2026The EU Youth Strategy 2019–2027 Adopted 477 for, 124 against, 66 abstainedPosition: For Majority line: For
15 Sept 2026Global role of the euro Adopted 405 for, 146 against, 60 abstainedPosition: For Majority line: For
9 Jul 2026Establishment of the digital euro Negotiating mandate approved 416 for, 169 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Adopted 476 for, 28 against, 96 abstainedPosition: No vote recorded Majority line: For
9 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Adopted 510 for, 1 against, 86 abstainedPosition: No vote recorded Majority line: For
9 Jul 2026Feasibility of a 28th tax regime and its potential to support EU competitiveness Adopted 366 for, 192 against, 39 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement Consent given 479 for, 119 against, 65 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026Protection of the environment through criminal law Consent given 499 for, 99 against, 69 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026EU–Mexico Interim Agreement on Trade Consent given 474 for, 131 against, 60 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol) Consent given 625 for, 16 against, 20 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement Consent given 573 for, 35 against, 37 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets Objection passed 388 for, 248 against, 24 abstainedPosition: No vote recorded Majority line: For
8 Jul 2026Lead in certain fishing tackle Objection failed 197 for, 455 against, 7 abstainedPosition: No vote recorded Majority line: Against
8 Jul 2026Genetically modified maize NK603 × T25 Objection passed 460 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: Against

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 6 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Alma EZCURRA ALMANSA EPPSpain99 % of 1 579 shared89 %
Maravillas ABADÍA JOVER EPPSpain98 % of 4 976 shared89 %
Fernando NAVARRETE ROJAS EPPSpain98 % of 5 085 shared89 %
Antonio LÓPEZ-ISTÚRIZ WHITE EPPSpain98 % of 4 606 shared89 %
Carmen CRESPO DÍAZ EPPSpain98 % of 4 506 shared89 %
Gabriel MATO EPPSpain98 % of 4 687 shared89 %
Borja GIMÉNEZ LARRAZ EPPSpain98 % of 5 142 shared89 %
Susana SOLÍS PÉREZ EPPSpain98 % of 4 451 shared89 %
Javier ZARZALEJOS EPPSpain97 % of 5 028 shared89 %
Pablo ARIAS ECHEVERRÍA EPPSpain97 % of 4 854 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia84 % of 4 716 shared82 %
Andreas GLÜCK RenewGermany83 % of 3 494 shared82 %
Dan BARNA RenewRomania83 % of 4 584 shared82 %
Bart GROOTHUIS RenewNetherlands83 % of 3 886 shared82 %
Hilde VAUTMANS RenewBelgium83 % of 5 102 shared82 %
Katri KULMUNI RenewFinland83 % of 4 095 shared82 %
Jan-Christoph OETJEN RenewGermany82 % of 5 102 shared82 %
Jeannette BALJEU RenewNetherlands82 % of 4 583 shared82 %
Eugen TOMAC RenewRomania82 % of 3 855 shared82 %
Olivier CHASTEL RenewBelgium82 % of 4 819 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute19 Jul 2024now
Committee on PetitionsPETI CommitteeMember8 Sept 2025now
Committee on Regional DevelopmentREGI CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with the countries of Central America, including the EU-Central America Association Parliamentary CommitteeDCAM DelegationVice-chair8 Jul 2025now
Delegation to the Euro-Latin American Parliamentary AssemblyDLAT Parliamentary assemblyVice-chair30 Sept 2024now
Intergroup on Attracting Investment to Ensure a Competitive and Sustainable European UnionIG10-03 Intergroup / working groupMember31 Jan 2025now
Intergroup on Biodiversity, Hunting and CountrysideIG10-04 Intergroup / working groupMember4 Feb 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Cohesion Policy and Outermost RegionsIG10-08 Intergroup / working groupMember25 Feb 2025now

Show all 20 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Mission to Santa Cruz de Tenerife (Spain)Official delegationDLAT11 Sept 2026
Deliberations of the Committee on Petitions in 2025Shadow rapporteurPETI11 Sept 2026
No dossier namedOfficial delegationREGI10 Jul 2026
No dossier namedOfficial delegationSANT25 Jun 2026
EuroLat Parliamentary Assembly meetings in Mexico City (26-28 May 2026)Official delegationDLAT12 May 2026
EU rare disease action planShadow rapporteurSANT6 Mar 2026
EU rare disease action planShadow rapporteurSANT28 Jan 2026
Establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034Shadow rapporteur for an opinionTRAN28 Jan 2026
Establishing the European Social Fund as part of the National and Regional Partnership Plan set out in Regulation (EU) […] [NRPPlan] establishing conditions for the implementation of the Union support to quality employment, skills and social inclusion for the period from 2028 to 2034Shadow rapporteur for an opinionREGI16 Jan 2026
No dossier namedOfficial delegationREGI28 Jul 2025
No dossier namedDelegation vice-chairDCAM7 Jul 2025
DCAM Constitutive Meeting in Costa Rica (21-23 July 2025)Official delegationDCAM7 Jul 2025
No dossier namedOfficial delegationPETI11 Apr 2025
No dossier namedOfficial delegationTRAN8 Apr 2025
EuroLat Bureau meeting in San SalvadorOfficial delegation30 Jan 2025
Opinion to BUDG-ECON: Implementation report of the Recovery and Resilience FacilityShadow rapporteur for an opinionTRAN18 Dec 2024
BUDG own-initiative report ‘A revamped long-term budget for the Union in a changing world’Shadow rapporteur for an opinionREGI13 Nov 2024
Own-initiative reportShadow rapporteur for an opinionREGI23 Oct 2024
No dossier namedDelegation vice-chairDCAM27 Sept 2024
No dossier namedDelegation vice-chairDLAT26 Sept 2024

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

38 contributions recorded; 2 on behalf of their group; 53 minutes of speaking time.

Show all 38 recent contributions

Questions and motions, 54

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
16 Sept 2026Gender gap in cardiovascular health and clinical research E-10-2026-003707Written questionNot yet answered
1 Jul 2026Procedure for banning monacolin K E-10-2026-002725Written questionwith 3 co-authorsNot yet answered
24 Jun 2026Continuity in mental health initiatives E-10-2026-002598Written question24 Aug 2026
15 Jun 2026MOTION FOR A RESOLUTION Political prisoners in Nicaragua – the cases of Carlos Brenes, Salvadora del Socorro Martínez Aburto and Brooklyn Rivera B-10-2026-0292Motion for a resolutionwith 26 co-authors—
12 Jun 2026MOTION FOR A RESOLUTION on the political repression and humanitarian situation in Cuba B-10-2026-0285Motion for a resolutionwith 6 co-authors—
9 Jun 2026Strengthening prevention, mental well-being and healthy ageing through improved hearing health E-10-2026-002380Written questionwith 15 co-authors21 Aug 2026
5 May 2026NextGenerationEU funds in Spain E-10-2026-001831Written questionwith 4 co-authors16 Sept 2026
5 May 2026NextGenerationEU funds in Spain E-10-2026-001830Written questionwith 4 co-authors27 Jul 2026
27 Mar 2026Ensuring that the fight against cancer remains a priority in the next multiannual financial framework (MFF) 2028-2034 E-10-2026-001292Written question4 Jun 2026
27 Mar 2026Strategic autonomy of the European Union and preparedness for health crises in the next multiannual financial framework E-10-2026-001291Written question15 Jun 2026

Show all 54 questions and motions

Amendments tabled in committee, 139

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
16 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792057 REGI17
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT12
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT4
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ643
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ645
7 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792058 REGI21
27 Aug 2026Cohesion policy in the EU’s eastern border regions: strengthening territorial resilience and cross-border cooperation REGI-AM-791869 REGI6
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT6
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3

Show all 139 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Spain National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Elena NEVADO DEL CAMPO”. Member record. memberId 257039. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257039?roles=all&rows=all&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257039. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257039?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257039,
  author = {{EU Parl Watch Research}},
  title = {{Elena NEVADO DEL CAMPO}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257039?roles=all&rows=all&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/257039?roles=all&rows=all&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257039. Official source: https://www.europarl.europa.eu/meps/en/257039. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}